Fertility Testing Is Big Business—But Is It Really Helping You Get Pregnant?
By Elissa Strauss,
Glamour Magazine [cites CGS' Fellow Gina Maranto]
| 12. 28. 2017
New evidence shows that the tests many companies use to determine a woman's chances of having a baby are based on bogus science.
"Learn how many high quality eggs you have remaining and your chances of getting pregnant now and in the future,” beckons Egg-Q, one of the handful of new startups offering fertility testing to women concerned about their reproductive potential. The desire to know “how long you have left to conceive,” as offered by LetsGetChecked, or, more simply, “powerful information about your fertility,” courtesy of Modern Fertility, is understandable. Women are having children later than ever, a shift that has proved professionally and personally beneficial, but reproductively challenging. When offered a fertility magic eight ball, many can’t help but take a peek, hoping to discover something, anything, about their baby-making future.
If only that was possible.
These fertility blood tests provide women with an assortment of figures and graphs charting their ovarian reserve, along with a few other measures that will present themselves as authoritative, fate-determining even. But in reality, they offer little more than...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...